 Visualization of AMPA receptors (AMPARs) distribution in dendrites.
Introduction
Tau, a microtubule-associated protein, is involved in both the development and degradation of the nervous system. It is well known that tau aggregates in aging neurons and is involved in the formation of tauopathies such as Alzheimer's disease (AD) [1] . During brain development, tau is present in a highly phosphorylated transient state, which progressively disappears from cortical neurons during postnatal life [2] . Phosphorylated tau is present at a high level only during periods of intense neuritic outgrowth and disappears during periods of neurite stabilization and synaptogenesis [3] . Recently, evidence has shown an important role for phosphorylated tau in synaptic plasticity [4] . These findings support the idea that tau and phosphorylated tau contribute to the control of the dynamic states of neurites and synapses.
Synaptic plasticity, such as long-term depression (LTD) and long-term potentiation (LTP), results in activity-dependent alterations in the strength of excitatory synaptic transmission and is mediated by alterations in the number of AMPA-type glutamate receptors (AMPARs) at synapses. NMDA-type glutamate receptor activation induces AMPAR trafficking from synapses [5, 6, 7, 8, 9] , and AMPARs are transported intracellularly in Rab11-positive recycling endosomes [10, 11, 12] .
Evidence of tau's contribution to synaptic functions is controversial. Studies using in vivo, ex vivo, and organotypic culture preparations have reported the importance of tau at synapses for LTD, but not for LTP [4, 13] . In contrast, it has also been reported that tau deficiency affects LTP, but not LTD [14] . Although the reasons for these discrepancies are still unclear, the influence of tau on synaptic plasticity suggests its involvement in the meta-plastic control of synapses, which is strongly influenced by the dynamic states of extra-synaptic receptor stocks and their trafficking [15] . Based on these findings, in the present study, we investigated the effects of tau deletion on the intra-dendritic distribution of AMPARs in hippocampal neurons using biochemical and laser-confocal imaging techniques.
Materials and Methods

Animals
Male and female C57/BL6J mice, which were kept on a light/dark cycle (12 h/12 h) at 23°C, were used for all experiments except where otherwise noted. Tau-deficient mice (Mapt tm1Hnd /J; The Jackson Laboratory) were maintained by backcrossing with C57/BL6J mice under the same conditions. All animals had free access to food and water. All experimental procedures were approved by the Committee for Animal Research of the National Center for Geriatrics and Gerontology.
Acute slice preparation for biochemical experiments
Hippocampus-entorhinal cortex slice preparations were used for biochemical experiments. After decapitation, the brain was isolated from 4-to 7-month-old male wild-type or tau-deficient mice and was horizontally sliced at a thickness of 350 m using a Vibratome (VT1200S, Leica). Then the hippocampus-entorhinal area was dissected from each slice under binocular vision. From each brain, six hippocampus-entorhinal slices were randomly collected from the obtained ones and were placed on a polycarbonate membrane (Transwell 3428, Corning) and submerged in artificial CSF (ACSF) (composition in mM: 124 NaCl, 26 NaHCO3, 10 glucose, 3 KCl, 1 MgSO4, 1.25 KH2PO4, 2 CaCl2) bubbled with 95% O2 and 5% CO2 at 34°C.
To determine changes in GluA2 levels in the postsynaptic density (PSD) over time, 24 slices obtained from two mice were randomly divided into the following four groups (six slices in each group): vehicle-treated controls, chemical LTD +0 min, chemical LTD +20 min, and chemical LTD +60 min. After incubation for 6 h, the slices of the three LTD groups were exposed to AMPA receptor antagonist (20 μM NBQX, Wako) for 3 min to perturb the influence of epileptic activity driven by NMDA and then to 20 μM NMDA (Sigma) in ACSF with 20 μM NBQX at 34°C for 3 min to induce chemical LTD. The slices in the control group were treated only with 20 μM NBQX for 6 min at 34°C. After washing with ACSF, slices were incubated in ACSF for 0 (chemical LTD +0 min group), 20 (chemical LTD +20 min group), or 60 (chemical LTD +60 min group) min. After incubation, the slices in each group were frozen in liquid nitrogen and stored at -80°C until used for biochemical experiments.
Preparation of modified-RIPA (mRIPA)-soluble and -insoluble fractions
Frozen slices were quickly weighed and then homogenized with 30 volumes (ml/g) of cold HEPES buffer (320 mM sucrose; 4 mM HEPES; 2 mM EDTA, pH 7.4) and centrifuged at 1,000 × g for 5 min at 4°C to remove nuclear material and cell debris. The supernatants (total fraction; S1) were centrifuged at 100,000 × g for 1 h at 4°C to obtain pellets containing synaptic structures. The pellets (crude synaptic fraction; P2) were re-suspended in an equal volume of mRIPA buffer (150 mM NaCl; 20 mM HEPES; 2 mM EDTA; 1% Triton X-100; 0.1% SDS, pH 7.4), gently sonicated, and incubated for 2 h at 4°C. The suspension was then centrifuged at 16,000 × g for 10 min at 4°C. The pellets were enriched in PSDs (mRIPA-insoluble fraction), and the supernatant contained detergent-soluble membrane proteins (mRIPA-soluble fraction). Protease inhibitor cocktail (Sigma) was used in all extraction steps. 
Organotypic slice culture for biochemical experiments
Hippocampi from 6-day-old male and female mice were isolated, and 400-m-thick slices were cut using a McIlwain tissue chopper (Mickle Laboratory Engineering, Guildford, UK) in ice-cold ACSF saturated with 95% O2 and 5% CO2. To reduce the extent of neuronal damage, 0.01% kynurenic acid (Sigma) was included in the ACSF. Slices were transferred to MilliCell culture plate inserts (#PICM03050, Millipore) with 6-10 slices on each insert. Inserts were placed in 6-well culture plates. Each well contained 1 ml of slice culture medium, which consisted of 50% MEM (#11095, Gibco), 25% heat-inactivated horse serum (#12449C, SAFC Bioscience), and 25% Earle's balanced salt solution (containing the following, in mM: 1.80 CaCl2, 0.81 MgSO4, 5.33 KCl, 26.19 NaHCO3, 117.24 NaCl, 1.01 NaH2PO4, 5.56 glucose, and 10 ng/ml insulin). Plates were maintained on a gently rocking platform in a humidified CO2 incubator (5% CO2, 95% atmospheric air) at 34°C for up to 2 months before experiments were performed. The medium was exchanged twice a week.
For chemical LTD treatment, the cultured slices were placed into the chamber of a perfusion system (maintained at 34°C) and exposed to NMDA solution as described above. The slices were incubated in ACSF for a further 0, 20, or 60 min and then were prefixed with 4% paraformaldehyde/4% sucrose in 0.1 M phosphate buffer (PB) (pH 7.4) for 10 min.
Detection of single neurons and immunostaining for GluA2
Neurons within the culture slices were visualized by an injection of Lucifer Yellow under an Olympus microscope (BX50WI) equipped with a 40× water immersion lens. The prefixed slices after NMDA treatment were submerged in 1 g/ml DAPI in 0.1 M phosphate buffered saline (PBS) to stain the cell nuclei. A glass electrode whose tip was filled with 10% (w/v) Lucifer Yellow CH dilithium salt (Sigma) was inserted into a neuronal cell, with the visualized cell nuclei being used to find neuronal cell bodies. Dye was loaded under a negative DC current of 10 nA for 15-30 min using an Axopatch 200B (Axon Instruments). The slices were incubated in 0.01 M PBS overnight at 4°C.
For GluA2 immunostaining, slices were fixed for 10 min with 4% paraformaldehyde/4% sucrose in 0.1 M PB, followed by 10 min with ice-cold 100% methanol at 4°C. After fixation, the slices were washed in 0.01 M PBS containing 0.1% Triton X-100 (PBS-TX) for 2.5 h at room temperature. Following blocking of non-specific binding with 5% normal goat serum in PBS-TX (PBS-TX-NGS) at 4°C overnight, the slices were incubated with GluA2 primary antibody (Millipore, 1:1000) in PBS-TX-NGS for 2-3 days at 4°C. The slices were then washed in PBS-TX for 2.5 h and treated with Alexa Fluor 647-conjugated secondary antibody (Abcam, 1:500) in PBS-TX-NGS for 1-2 days at 4°C. After being washed in PBS-TX for 3 h and rinsed in PBS for 10 min, the immunostained preparations were dehydrated in a graded 2-propanol series (70%, 80%, 90%, 100%), cleared in xylene, and mounted in Mount-Quick (Daido Sangyo, Japan). The preparations were observed and photographed using a confocal laser scanning microscope (LSM700, Zeiss), which was used to take z-stack images at a 0.1-μm step size.
Image quantification and statistical analysis
Quantification of confocal images was performed using ImageJ and MATLAB (version 2013, MathWorks) software. To define the dendrite of a Lucifer Yellow-labeled neuron, a 3D confocal image of background-subtracted green fluorescence was used. First, we selected two points within part of the labeled dendritic shank or branch by eye, between which our custom software automatically defined the analyzing area (a class of pixels closer to the line than the heads of spines, as defined by the selected points) and clipped the dendrite area by binarization with a threshold dynamically determined by the fluorescence distribution within the analyzed area. Then, its intra-dendritic area was obtained by removal of the area containing the edge around the binarized area from the dendritic area. Finally, the distribution of GluA2 fluorescence of the intra-dendritic areas was obtained. In the present study, the fluorescence intensity of the GluA2 signal in the intra-dendritic area was normalized using the mean fluorescence intensity of 10 of the most brilliant puncta in dendrites obtained in a 3D image. The size and density of GluA2 puncta were calculated using custom software for 3D particle analysis.
Statistical comparisons were made using a one-sample t-test, a unpaired t-test, a oneway ANOVA with Dunnett's post hoc analysis, or a two-way ANOVA using Prism 7 (GraphPad Software).
Results
Tau deletion increases the size of GluA2 puncta within dendrites under unstimulated conditions.
The basic distribution of GluA2-containing AMPARs was compared biochemically between wild-type and tau-deficient slices. In mRIPA-insoluble fractions, which contained high levels of PSD, including PSD-95 and synaptic receptors (Fig. 1A) , there was no difference between wild-type and tau-deficient slices in the density of synaptic GluA2 (Fig. 1D , GluA2/PSD-95; p = 0.782, unpaired t-test), suggesting normal transmission at tau-deficient synapses. This is consistent with prior studies, which investigated the influence of tau deletion on basic transmission at synapses [4, 11] . Additionally, a significant difference in the GluA2 expression level was not detected in the mRIPA-soluble fractions ( Fig. 1C; To analyze the distribution of GluA2-containing AMPARs within dendrites, we fluorescently visualized GluA2 in single neurons of organotypic hippocampal slice cultures in which dendritic arbors had been labeled by intracellular injection of Lucifer Yellow after fixation ( Fig. 2A) . This analysis showed that the fluorescence intensities of dendritic GluA2 in taudeficient neurons were significantly greater than those of wild-type neurons ( Fig. 2C ; p < 0.0001, unpaired t-test). A more detailed analysis of dendritic GluA2 puncta showed that the size of puncta in tau-deficient neurons (0.125 ± 0.007 m 3 , mean ± SEM; n = 499) was significantly larger than that of wild-type neurons (0.088 ± 0.004 m 3 , mean ± SEM; n = 440) ( Fig. 2D ; p < 0.0001, unpaired t-test) and that the densities of puncta were similar ( Fig. 2E ; p = 0.078, unpaired t-test).
These results suggest that tau deficiency affects mechanisms controlling the level of AMPARs within dendrites.
The absence of tau prevents NMDA-induced enlargement of GluA2 puncta within dendrites in multiple ways.
It has been reported that tau deletion prevents NMDA-induced chemical LTD [4, 14] .
To confirm this finding, temporal changes in GluA2 levels after treatment with 20 μM NMDA were compared in the wild-type and tau-deficient slices. Immediately after NMDA treatment, in wild-type slices, the ratio of GluA2 levels in the mRIPA-insoluble and mRIPA-soluble fractions was 75.8 ± 7.3% (mean ± SEM) of the one obtained from vehicle controls (Fig. 3A and C) , which received only NBQX treatment (see Materials and Methods). As shown in Fig. 3 , such a reduction of the ratio of GluA2 levels in the synaptic and extra-synaptic fractions was maintained for 1 h after NMDA treatment, as the total data obtained after the treatment (+0, +20, and +60 min: 82.9 ± 4.4% of controls) was significantly lower than the controls (p < 0.001, one-sample t-test). In contrast to the wild-type slices, the tau-deficient ones did not show any significant reduction in the parameter from the control level (+0 min: 98.6 ± 5.6%, p = 0.805, one-sample t-test; +20 min:
101.8 ± 3.3%, p = 0.595, one-sample t-test; +60 min: 103.4 ± 5.4%, p = 0.548, one-sample t-test; total data after NMDA: 101.3 ± 2.7%, p = 0.646, one-sample t-test). Furthermore, a two-way ANOVA analysis using data obtained from different time points after NMDA application ( To examine changes in AMPAR distribution within dendrites after NMDA treatment, intra-dendritic distribution of GluA2 at different time points after NMDA treatment was analyzed by a post-fixation labeling method (Fig. 4A) . Interestingly, in wild-type neurons, temporal change in the dendritic GluA2 signal showed a mixed pattern compared with that of synaptic GluA2 (Fig.   4B , WT) and was significantly increased immediately after NMDA treatment (p = 0.0266, Dunnett's multi-comparison test against non-treated control). We also found that the size of GluA2-postitive puncta was enlarged from 0.0880 ± 0.00413 μm 3 to 0.117 ± 0.00785 μm 3 immediately after NMDA treatment (p < 0.001, Dunnett's multi-comparison test against untreated control) (Fig. 4C, WT) . In contrast, no change in the number of GluA2 puncta was observed at any time point after NMDA treatment (Fig. 4D, WT) .
In contrast to wild-type neurons, tau-deficient neurons had an immediate decrease in their dendritic GluA2 signal immediately after NMDA treatment (p < 0.001, Dunnett's multicomparison test against untreated control) (Fig. 4B, KO) . Importantly, we did not detect any changes in GluA2 puncta size after NMDA treatment in tau-deficient neurons (Fig. 4C, KO) . This indicates that NMDA-induced enlargement of GluA2 puncta observed in wild-type neurons is a critical process for down-regulation of AMPARs in the PSD. Furthermore, in tau-deficient neurons, the number of GluA2 puncta within dendrites was reduced by 21.7% immediately after NMDA treatment (Fig. 4D, KO) . The rapid reduction of dendritic GluA2 puncta potentially acts to prevent their enlargement and the downregulation of AMPARs in the PSD. Therefore, these results from tau-deficient neurons demonstrate the multiple contributions of tau to the maintenance of dynamic AMPAR trafficking within dendrites in both stimulated and unstimulated conditions.
Discussion
Here we visualized the intra-dendritic distribution of GluA2-containing AMPARs in single dye-labeled neurons in fixed hippocampal slice cultures. The dye labeling method of fixed single neurons has been used to analyze the morphology of synapses [16, 17] . This method has the advantage of minimal artificial influence on experimental results in comparison with other methods, such as GFP expression, because the analyzed preparations are kept in an intact condition before fixation. In the present study, we three-dimensionally clipped the area within the dye-labeled dendrites and analyzed the distribution of GluA2, which indicated that there are critical differences in AMPAR dynamics within dendrites between wild-type and tau-deficient
neurons.
The present study shows the importance of the enlargement process of dendritic GluA2 puncta for LTD formation, a process that is attenuated by tau deletion. Rab11-positive recycling endosomes play a critical role as an AMPAR stock for LTD formation [18] . Thus, dendritic
GluA2 puncta may originate from recycling endosomes. Indeed, our immunohistochemical experiment showed that many of the GluA2 puncta within dendrites were positive for Rab11 expression (data not shown). Tau influences formation of the AMPAR-PICK1 association [4] , and association of PICK1 with Rab11 is an important process for AMPAR sorting in recycling endosomes [19] . Furthermore, we show here that tau deficiency perturbed enlargement of GluA2 puncta and stacking of AMPARs within dendrites after NMDA treatment. Taken together, these findings indicate that tau plays a crucial role in AMPAR stacking mechanisms within dendrites.
We also found that tau-deficient neurons show a rapid reduction in the number of GluA2 puncta immediately after NMDA treatment, although such a reduction was not observed in wildtype neurons. The rapid reduction of GluA2 puncta was not accompanied by changes in their size.
Thus, we speculate that the rapid change was the result of translocation of the puncta, rather than its diminishment or fission at each location. In neuronal axons, it has been reported that tau prevents kinesin-microtubule association [20, 21] . Therefore, tau potentially contributes to stabilization of cargo-like structures to be transferred by the kinesin-motor complex, although the mechanism determining the special stability of recycling endosomes in dendrites is still unclear.
As the recycled endosomes of intra-dendritic AMPAR stocks have important roles in both LTP and LTD formation [22, 23] , the phasic reduction of GluA2 puncta, which was associated with tau deletion and NMDA activation, potentially influences both processes. These findings provide additional evidence for the importance of tau for AMPAR trafficking within dendrites.
As described above, the data obtained in the present study show that tau contributes to the maintenance of AMPAR dynamics within dendrites in multiple ways. The resulting multiple influences of tau deficiency on AMPAR dynamics may explain the divergent findings about the role of tau in plasticity in two lines of tau knockout mice. Additionally, the finding that tau has multiple roles in dendritic function contributes to our current knowledge of the function of dendritic tau and our understanding of the basic mechanisms not only of synaptic plasticity or meta-plasticity but also of synaptic dysfunction related to tauopathies. 
